NetworkNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces Participation at Q4 Virtual Investor Summit
Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from mild-to-moderate obstructive sleep apnea (“OSA”), will be presenting at the upcoming Q4 Virtual Investor Summit. The summit is scheduled for Nov. 17, 2021. Vivos CEO Kirk Huntsman, chief financial officer Brad Amman, and investor relations officer Ed Loew will provide key information about the company during a life webcast slated to begin at 11:45 a.m. EST. To view the full presentation, visit https://nnw.fm/8j4FO To view the full press release, visit https://nnw.fm/ItHul About Vivos Therapeutics Inc. Vivos Therapeutics is a medical technology company focused…







